First-of-its-Kind Permanent Filter for Stroke Prevention in Atrial Fibrillation

We are committed to developing a new approach to stroke prevention in individuals with abnormal heart rhythm (atrial fibrillation). A stroke typically occurs when a blood clot travels through the arteries of the neck (carotid arteries) and reaches the brain. Our device, Vine™, is a permanent filter implanted in the carotid arteries designed to prevent anterior large vessel occlusion (LVO) strokes from occurring by intercepting such blood clots. Vine™ is implanted through a thin needle in a simple procedure lasting just minutes.

​

The first-in-human feasibility and safety study (CAPTURE) and the safety and performance study (CAPTURE II) have been completed.

 

The FDA pivotal trial, INTERCEPT, is now evaluating Vine™ in people with atrial fibrillation who have had an ischemic stroke within the past year. This randomized controlled trial is underway in the United States, Canada, and Europe, with sites in South America expected to begin enrolling soon.